Basic Information
Gene Structure
Domain
Regulation&
Interaction
Annotation
Orthologus Group
Pathway
Basic Information
Gene ID
CKAN_00783000.v3
View in Genome Browser
Position
CKAN.scaff0003:15416811-15422820 (-)
6009bp
Gene Type
gene
Gene Description (Protein Product)
Catalyzes the reduction of fatty acyl-CoA to fatty alcohols
Organism
Cinnamomum kanehirae
Also AS AT3G11980

Gene Structure

upstream:
Get Sequence

Domain
Database EntryID E-Value Start end InterPro ID Description

Regulation&Interaction
Protein-protein interaction (PPI)
CKAN_01001600.v3 O-acyltransferase (WSD1-like)
CKAN_02584300.v3 O-acyltransferase (WSD1-like)
CKAN_01355400.v3 Catalyzes the reduction of fatty acyl-CoA to fatty alcohols
Regulatory gene
CKAN_00053400.v3 Protein SENSITIVE TO PROTON RHIZOTOXICITY
CKAN_00082000.v3 ZINC FINGER protein
CKAN_00090300.v3 Zinc finger AN1 and C2H2 domain-containing stress-associated protein

Load All Networks

Annotation

Orthologous Group
Orthologous ID Species Number All hits in PereRegDB Hits of this species Orthologous Detail


Pathway
Go Pathway KEGG Pathway
GO Term Description GO Category
GO:0003674 molecular_function MF
GO:0003824 catalytic activity MF
GO:0005575 cellular_component CC
GO:0005622 intracellular anatomical structure CC
GO:0005623 obsolete cell CC
GO:0006139 nucleobase-containing compound metabolic process BP
GO:0006163 purine nucleotide metabolic process BP
GO:0006637 acyl-CoA metabolic process BP
GO:0006725 cellular aromatic compound metabolic process BP
GO:0006732 obsolete coenzyme metabolic process BP
GO:0006753 nucleoside phosphate metabolic process BP
GO:0006790 sulfur compound metabolic process BP
GO:0006793 phosphorus metabolic process BP
GO:0006796 phosphate-containing compound metabolic process BP
GO:0006807 nitrogen compound metabolic process BP
GO:0007275 multicellular organism development BP
GO:0008150 biological_process BP
GO:0008152 metabolic process BP
GO:0009058 biosynthetic process BP
GO:0009117 nucleotide metabolic process BP
GO:0009150 purine ribonucleotide metabolic process BP
GO:0009259 ribonucleotide metabolic process BP
GO:0009555 pollen development BP
GO:0009653 anatomical structure morphogenesis BP
GO:0009698 phenylpropanoid metabolic process BP
GO:0009699 phenylpropanoid biosynthetic process BP
GO:0009987 cellular process BP
GO:0010208 pollen wall assembly BP
GO:0010345 suberin biosynthetic process BP
GO:0010584 pollen exine formation BP
GO:0010927 cellular component assembly involved in morphogenesis BP
GO:0016043 cellular component organization BP
GO:0016491 oxidoreductase activity MF
GO:0016620 oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor MF
GO:0016627 oxidoreductase activity, acting on the CH-CH group of donors MF
GO:0016628 oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor MF
GO:0016903 oxidoreductase activity, acting on the aldehyde or oxo group of donors MF
GO:0019438 aromatic compound biosynthetic process BP
GO:0019637 organophosphate metabolic process BP
GO:0019693 ribose phosphate metabolic process BP
GO:0019748 secondary metabolic process BP
GO:0022607 cellular component assembly BP
GO:0030198 extracellular matrix organization BP
GO:0032501 multicellular organismal process BP
GO:0032502 developmental process BP
GO:0032989 cellular component morphogenesis BP
GO:0033865 nucleoside bisphosphate metabolic process BP
GO:0033875 ribonucleoside bisphosphate metabolic process BP
GO:0034032 purine nucleoside bisphosphate metabolic process BP
GO:0034641 cellular nitrogen compound metabolic process BP
GO:0035336 long-chain fatty-acyl-CoA metabolic process BP
GO:0035337 fatty-acyl-CoA metabolic process BP
GO:0035383 thioester metabolic process BP
GO:0043062 extracellular structure organization BP
GO:0043226 organelle CC
GO:0043227 membrane-bounded organelle CC
GO:0043229 intracellular organelle CC
GO:0043231 intracellular membrane-bounded organelle CC
GO:0043603 amide metabolic process BP
GO:0044085 cellular component biogenesis BP
GO:0044237 cellular metabolic process BP
GO:0044238 primary metabolic process BP
GO:0044249 cellular biosynthetic process BP
GO:0044281 small molecule metabolic process BP
GO:0044424 obsolete intracellular part CC
GO:0044464 obsolete cell part CC
GO:0044550 secondary metabolite biosynthetic process BP
GO:0045229 external encapsulating structure organization BP
GO:0046483 heterocycle metabolic process BP
GO:0048229 gametophyte development BP
GO:0048646 anatomical structure formation involved in morphogenesis BP
GO:0048856 anatomical structure development BP
GO:0048869 cellular developmental process BP
GO:0051186 obsolete cofactor metabolic process BP
GO:0055086 nucleobase-containing small molecule metabolic process BP
GO:0055114 obsolete oxidation-reduction process BP
GO:0071704 organic substance metabolic process BP
GO:0071840 cellular component organization or biogenesis BP
GO:0072521 purine-containing compound metabolic process BP
GO:0080019 fatty-acyl-CoA reductase (alcohol-forming) activity MF
GO:0085029 extracellular matrix assembly BP
GO:1901135 carbohydrate derivative metabolic process BP
GO:1901360 organic cyclic compound metabolic process BP
GO:1901362 organic cyclic compound biosynthetic process BP
GO:1901564 organonitrogen compound metabolic process BP
GO:1901568 fatty acid derivative metabolic process BP
GO:1901576 organic substance biosynthetic process BP
KEGG Term Name Description
map04146 Peroxisome Peroxisomes are essential organelles that play a key role in redox signalling and lipid homeostasis. They contribute to many crucial metabolic processes such as fatty acid oxidation, biosynthesis of ether lipids and free radical detoxification. The biogenesis of peroxisomes starts with the early peroxins PEX3, PEX16 and PEX19 and proceeds via several steps. The import of membrane proteins into peroxisomes needs PEX19 for recognition, targeting and insertion via docking at PEX3. Matrix proteins in the cytosol are recognized by peroxisomal targeting signals (PTS) and transported to the docking complex at the peroxisomal membrane. Peroxisomes' deficiencies lead to severe and often fatal inherited peroxisomal disorders (PD). PDs are usually classified in two groups. The first group is disorders of peroxisome biogenesis which include Zellweger syndrome, and the second group is single peroxisomal enzyme deficiencies.